Wordt geladen...
Megestrol acetate for cachexia–anorexia syndrome. A systematic review
In 1993, megestrol acetate (MA) was approved by the US Food and Drug Administration for the treatment of anorexia, cachexia, or unexplained weight loss in patients with acquired immunodeficiency syndrome. The mechanism by which MA increases appetite is unknown, and its effectiveness for anorexia and...
Bewaard in:
| Gepubliceerd in: | J Cachexia Sarcopenia Muscle |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5989756/ https://ncbi.nlm.nih.gov/pubmed/29542279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12292 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|